Back to Markets
RARapport Therapeutics Inc

Rapport Therapeutics Inc

RAPPNASDAQ NMS - GLOBAL MARKET
Health CarePharmaceuticals

$39.50

+0.0100 (+0.03%)

As of 05/29/26 EDT · USD

Compare
Low: $8.20Current: $39.50High: $42.27

Key Statistics

Open

$39.06

Day High

$39.69

Day Low

$38.14

Prev. Close

$39.49

VolumeShares traded today.

263.44K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$1.89B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-15.18

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$42.27

52W LowLowest price over the past 52 weeks.

$8.20

50D MAAverage closing price over the last 50 trading days.

$34.82

200D MAAverage closing price over the last 200 trading days.

$28.40

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+7.6%

1M

+19.7%

6M

+38.2%

YTD

+40.5%

1Y

+377.6%

About

Steven M. Paul is an American neuroscientist, psychiatrist, and biopharmaceutical executive. As of 2025, Paul is the co-founder and board chair of Rapport Therapeutics and Seaport Therapeutics. He is the former CEO and board chair of Karuna Therapeutics. Paul is a Venture Partner at Third Rock Ventures. Paul is also a professor of psychiatry and neurology at Washington University School of Medicine in St. Louis.

www.rapportrx.com/

Company Facts

SectorHealth Care
IndustryPharmaceuticals
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade RAPP

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.